AbbVie (NYSE: ABBV)

Industries Pharmaceuticals Biotechnology and Life Sciences
Subsidiaries Allergan PLC, Cerevel Therapeutics Holdings, Inc., ImmunoGen, Inc.
Number of Facilities: 4

Total Estimated Sanctions (3-year Avg.) More information

$169,620,585

* AbbVie has disclosed their China operations data.

Average Annual Revenue More information

Global $45,537,000,000
China Revenue 1.12% $511,666,667

Annual Average of Total Assets More information

Global $116,240,666,667
China Assets 1.15% $1,334,750,301

Facilities & Trade in China

Total Export Dollars $164,035
Ports of Exit 1

Annual Revenue More information


2018 2020 2022
Global Data $32,753,000,000 $45,804,000,000 $58,054,000,000
China Data $152,000,000 $471,000,000 $912,000,000

Operating Expense More information


2018 2020 2022
Global Data $18,652,000,000 $19,054,000,000 $22,523,000,000
China Data $86,560,132 $195,931,229 $353,825,335

Total Assets More information


2018 2020 2022
Global Data $59,352,000,000 $150,565,000,000 $138,805,000,000
China Data $275,440,540 $1,548,251,572 $2,180,558,790

Cost of Goods Sold for Chinese Activity More information


2018 2020 2022
Global Data $7,718,000,000 $15,387,000,000 $17,414,000,000
China Data $35,817,666 $158,223,670 $273,565,439

Operating Profits / Total Assets More information


2018 2020 2022
Global Data 10.75% 7.55% 13.05%
China Data 10.75% 7.55% 13.05%

Operating Profits More information


2018 2020 2022
Global Data $6,383,000,000 $11,363,000,000 $18,117,000,000
China Data $29,622,203 $116,845,101 $284,609,226